Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA)

go back to reference Hochman JS, Tamis JE, Thompson TD et al (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. N Engl J Med 341:226–232CrossRef Hochman JS, Tamis JE, Thompson TD et al (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. N Engl J Med 341:226–232CrossRef

go back to reference Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD (2019) ESC scientific document group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 40:237–269CrossRef Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD (2019) ESC scientific document group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 40:237–269CrossRef

go back to reference Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P (2017) WG on cardiovascular pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 38:143–153PubMed Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P (2017) WG on cardiovascular pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 38:143–153PubMed

go back to reference Vargas KG, Haller PM, Jäger B, Tscharre M, Binder RK, Mueller C, Lindahl B, Huber K (2018) Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1403-3[Epub ahead of print] CrossRefPubMed Vargas KG, Haller PM, Jäger B, Tscharre M, Binder RK, Mueller C, Lindahl B, Huber K (2018) Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis. Clin Res Cardiol. https://​doi.​org/​10.​1007/​s00392-018-1403-3[Epub ahead of print] CrossRefPubMed

go back to reference Sandoval Y, Thordsen SE, Smith SW, Schulz KM, Murakami MM, Pearce LA, Apple FS (2014) Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 3:317–325CrossRef Sandoval Y, Thordsen SE, Smith SW, Schulz KM, Murakami MM, Pearce LA, Apple FS (2014) Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 3:317–325CrossRef

go back to reference Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study. J Am Coll Cardiol 52:523–527CrossRef Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study. J Am Coll Cardiol 52:523–527CrossRef

go back to reference Wang CH, Kuo LT, Hung MJ et al (2002) Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J 144:275–281CrossRef Wang CH, Kuo LT, Hung MJ et al (2002) Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J 144:275–281CrossRef

go back to reference Nakayama N, Kaikita K, Fukunaga T, Matsuzawa Y, Sato K, Horio E, Yoshimura H, Mizobe M, Takashio S, Tsujita K, Kojima S, Tayama S, Hokimoto S, Sakamoto T, Nakao K, Sugiyama S, Kimura K, Ogawa H (2014) Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome. J Am Heart Assoc 3:e000795CrossRef Nakayama N, Kaikita K, Fukunaga T, Matsuzawa Y, Sato K, Horio E, Yoshimura H, Mizobe M, Takashio S, Tsujita K, Kojima S, Tayama S, Hokimoto S, Sakamoto T, Nakao K, Sugiyama S, Kimura K, Ogawa H (2014) Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome. J Am Heart Assoc 3:e000795CrossRef

go back to reference Yu M, Zhang Q, Huang X (2018) Acute coronary syndrome due to right coronary spasm and documented lambda-like J waves. Clin Res Cardiol 107:729–732CrossRef Yu M, Zhang Q, Huang X (2018) Acute coronary syndrome due to right coronary spasm and documented lambda-like J waves. Clin Res Cardiol 107:729–732CrossRef

go back to reference Montone RA, Niccoli G, Fracassi F, Russo M, Gurgoglione F, Cammà G, Lanza GA, Crea F (2018) Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 39:91–98PubMed Montone RA, Niccoli G, Fracassi F, Russo M, Gurgoglione F, Cammà G, Lanza GA, Crea F (2018) Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 39:91–98PubMed

go back to reference Grodzinsky A, Arnold SV, Gosch K, Spertus JA, Foody JM, Beltrame J, Maddox TM, Parashar S, Kosiborod M (2015) Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease. Eur Heart J Qual Care Clin Outcomes 1:92–99CrossRef Grodzinsky A, Arnold SV, Gosch K, Spertus JA, Foody JM, Beltrame J, Maddox TM, Parashar S, Kosiborod M (2015) Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease. Eur Heart J Qual Care Clin Outcomes 1:92–99CrossRef

go back to reference Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J 2013(34):2949–3003 Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J 2013(34):2949–3003

go back to reference Yilmaz A, Mahrholdt H, Athanasiadis A, Vogelsberg H, Meinhardt G, Voehringer M, Kispert EM, Deluigi C, Baccouche H, Spodarev E, Klingel K, Kandolf R, Sechtem U (2008) Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 94:1456–1463CrossRef Yilmaz A, Mahrholdt H, Athanasiadis A, Vogelsberg H, Meinhardt G, Voehringer M, Kispert EM, Deluigi C, Baccouche H, Spodarev E, Klingel K, Kandolf R, Sechtem U (2008) Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 94:1456–1463CrossRef

go back to reference Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitsu K (2017) Overview of the pharmacological spasm provocation test: comparisons between acetylcholine and ergonovine. J Cardiol 69:57–65CrossRef Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitsu K (2017) Overview of the pharmacological spasm provocation test: comparisons between acetylcholine and ergonovine. J Cardiol 69:57–65CrossRef

go back to reference Gross L, Epstein EZ, Kugel MA (1934) Histology of the coronary arteries and their branches in the human heart. Am J Pathol 10(253–274):7PubMed Gross L, Epstein EZ, Kugel MA (1934) Histology of the coronary arteries and their branches in the human heart. Am J Pathol 10(253–274):7PubMed

go back to reference Thorin E (2001) Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38:90–98CrossRef Thorin E (2001) Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38:90–98CrossRef

go back to reference Pelliccia F, Kaski JC, Crea F, Camici PG (2017) Pathophysiology of takotsubo syndrome. Circulation 135:2426–2441CrossRef Pelliccia F, Kaski JC, Crea F, Camici PG (2017) Pathophysiology of takotsubo syndrome. Circulation 135:2426–2441CrossRef

go back to reference Gassanov N, Le MT, Caglayan E, Hellmich M, Erdmann E, Er F (2019) Novel ECG-based scoring tool for prediction of takotsubo syndrome. Clin Res Cardiol 108:68–73CrossRef Gassanov N, Le MT, Caglayan E, Hellmich M, Erdmann E, Er F (2019) Novel ECG-based scoring tool for prediction of takotsubo syndrome. Clin Res Cardiol 108:68–73CrossRef